As the market continues with wild up and down swings (mostly down), these two microcaps have been turning a blind eye to the death and destruction in the market.
XTL Biopharmaceuticals Ltd. (Stock Symbol: XTLB) is engaged in the development of therapeutics for the treatment of diabetic neuropathic pain and HCV. XTL is developing Bicifadine, a serotonin and norepinephrine reuptake inhibitor, for the treatment of diabetic neuropathic pain.
Tollgrade Communications, Inc. (Stock Symbol: TLGD) is a provider of hardware and software network assurance testing solutions for the telecommunications and cable broadband industries. The Company provides equipment that enables telephone companies to evaluate problems so they can ultimately repair their wire telephone lines when they are not functioning properly. When the telephone lines are out of service, the Company’s products help to diagnose the problem.
Both of these companies have taken a beating but have been bouncing up off the canvas lately for some nice gains. If the market decides to head toward its 50 day moving average, these stocks might be a bargain.